Quick Summary
This editorial argues that three related conditions—POTS, ME/CFS, and Long COVID—should be understood and studied together as disorders affecting both the nervous system and immune system. The authors identify several common problems in these conditions, including heart rate abnormalities when standing, immune system dysfunction, and reduced blood flow to the brain. They believe treating these as a single category of disease could improve how doctors train, research, and care for patients with these serious illnesses.
Why It Matters
This perspective is important because it validates the interconnected nature of conditions that often co-occur or overlap in patients, potentially leading to more integrated research and clinical approaches. If adopted, this framework could improve physician understanding and training, leading to better recognition and management of these disabling conditions that currently lack disease-modifying treatments.
Observed Findings
What the study reports it measured.
- POTS and ME/CFS are the most common phenotypes of Long COVID
- These three conditions share overlapping complex, multi-systemic pathophysiology
- Identified mechanistic factors include autonomic dysfunction, immune dysregulation, autoimmunity, mitochondrial dysfunction, cerebral hypoperfusion, and neuroinflammation
- These conditions cause significant disability and functional impairment in patients
- The exact pathophysiologic mechanisms are still being investigated
Inferred Conclusions
What the authors interpret from those results.
- POTS, ME/CFS, and Long COVID should be conceptualized as neuroimmune disorders
- These conditions require integration into neuroimmunology subspecialty with dedicated educational curriculum and training pathways
- A unified neuroimmunologic framework is key to advancing both basic science and clinical care for this underserved patient population
- Current clinical care and research approaches are inadequate for these complex disorders
Remaining Questions
- What are the distinct vs. shared mechanisms driving POTS, ME/CFS, and Long COVID in different patient subsets?
- How should diagnostic criteria and treatment protocols be standardized under a neuroimmune framework?
- What specific curriculum and training changes would best prepare clinicians to diagnose and manage these disorders?
- Will reclassification as neuroimmune disorders lead to improved patient outcomes and access to care?
What This Study Does Not Prove
This editorial does not provide original experimental data, mechanistic proof, or clinical trials establishing causation for any proposed pathways. It does not demonstrate the prevalence of individual mechanisms across patient populations or prove that reclassification will improve patient outcomes. The piece represents expert opinion rather than empirical evidence of pathophysiology.
Explore further
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Cite this study
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Blitshteyn, Svetlana, Doherty, Taylor A, & Steinman, Lawrence (2026). Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorders.. ImmunoTargets and therapy. https://doi.org/10.2147/ITT.S581262
BibTeX
@article{mecfsatlas-blitshteyn-2026-postural-orthostatic,
author = {Blitshteyn, Svetlana and Doherty, Taylor A and Steinman, Lawrence},
title = {Postural Orthostatic Tachycardia Syndrome, Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Long COVID as Neuroimmune Disorders.},
journal = {ImmunoTargets and therapy},
year = {2026},
doi = {10.2147/ITT.S581262},
note = {PubMed: 41859298},
url = {https://www.mecfsatlas.com/evidence/blitshteyn-2026-postural-orthostatic},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-11-14. https://www.mecfsatlas.com/evidence/blitshteyn-2026-postural-orthostatic
Contribute
Private, reviewed by a human. Not a public comment thread.